Revenue and Profit Performance - Total revenues for Q2 2024 were 9.1billion,up0.3 billion (4%) from the previous year, driven by an increase in Commercial Engines & Services[12] - Adjusted earnings per share for Q2 2024 was 1.20,withaprofitmarginof15.91.5 billion (9%) to 18.0billion,withequipmentrevenuesupduetohigherpricesandfavorablemix,andservicesrevenuesupduetoincreasedshopvisitvolumeandspareparts[19]−ContinuingearningsforthethreemonthsendedJune30,2024increasedby0.1 billion to 1.3billion,drivenbya0.4 billion increase in segment profit and a 0.1billiondecreaseinprovisionforincometaxes[20]−AdjustedearningsforthethreemonthsendedJune30,2024were1.3 billion, an increase of 0.5billion,primarilyduetoa0.4 billion increase in segment profit and lower Adjusted Corporate & Other operating costs[20] - For the six months ended June 30, 2024, continuing earnings decreased by 4.7billion,primarilyduetoa6.0 billion decrease in gains on retained and sold ownership interests, partially offset by a 0.7billionincreaseinsegmentprofit[21]−Totalrevenues(GAAP)forQ22024were9.094 billion, a 4% increase compared to 8.755billioninQ22023[76]−Adjustedrevenues(Non−GAAP)forQ22024were8.223 billion, up 4% from 7.907billioninQ22023[76]−Operatingprofit(Non−GAAP)forQ22024was1.897 billion, a 37% increase from 1.385billioninQ22023[76]−Operatingprofitmargin(Non−GAAP)improvedto23.11.320 billion, or 1.20pershare,comparedto1.195 billion, or 1.09pershare,inQ22023[78]−Adjustedearnings(Non−GAAP)forQ22024were1.321 billion, or 1.20pershare,comparedto812 million, or 0.74pershare,inQ22023[78]−TotalrevenuesforthethreemonthsendedJune30,2024,were9,094 million, compared to 8,755millioninthesameperiodin2023[84]−NetearningsattributabletocommonshareholdersforthethreemonthsendedJune30,2024,were1,266 million, compared to a loss of 25millioninthesameperiodin2023[84]−DilutedearningspersharefromcontinuingoperationsforthethreemonthsendedJune30,2024,were1.20, compared to 1.09inthesameperiodin2023[84]−NetearningsforthesixmonthsendedJune30,2024,were2.833 billion, compared to 7.518billioninthesameperiodin2023[86]−EarningspersharefromcontinuingoperationsforQ22024increasedto1.20 (diluted) and 1.21(basic),comparedto1.09 (diluted) and 1.10(basic)inQ22023[148]−NetearningsattributabletocommonshareholdersforQ22024were1.266 billion, a significant improvement from a net loss of 25millioninQ22023[148]−EarningsfromcontinuingoperationsattributabletocommonshareholdersforQ22024were1.320 billion, up from 1.195billioninQ22023[177]CashFlowandFinancialPosition−Cashflowsfromoperatingactivities(CFOA)forthesixmonthsendedJune30,2024,were2.6 billion, up from 1.6billioninthesameperiodin2023[14]−Freecashflows(FCF)forthesixmonthsendedJune30,2024,were2.8 billion, compared to 1.8billioninthesameperiodin2023[14]−Totalcash,cashequivalents,andrestrictedcashwas12.1 billion at June 30, 2024, with 5.0billionheldintheU.S.and7.1 billion held outside the U.S.[54] - The company repurchased 11.7 million shares for 1.9billionduringthethreemonthsendedJune30,2024,undera15.0 billion share repurchase authorization[59] - Consolidated total borrowings decreased by 0.9billionto19.7 billion at June 30, 2024, mainly due to maturities[59] - The company received 2.6billionfromthedispositionof31.1millionsharesofGEHealthCareinthefirstquarterof2024,witharemaininginterestof30.5millionsharesasofJune30,2024[58]−Freecashflows(Non−GAAP)forthefirstsixmonthsof2024were2.767 billion, compared to 1.770billioninthesameperiodof2023[80]−Cashflowsfromoperatingactivities(GAAP)forthefirstsixmonthsof2024were2.586 billion, up from 1.564billioninthesameperiodof2023[80]−TotalassetsasofJune30,2024,were123,190 million, compared to 173,300millionasofDecember31,2023[85]−Cash,cashequivalents,andrestrictedcashasofJune30,2024,were12,107 million, compared to 15,204millionasofDecember31,2023[85]−TotalliabilitiesasofJune30,2024,were104,347 million, compared to 144,695millionasofDecember31,2023[85]−Totalshareholders′equityasofJune30,2024,was18,598 million, compared to 27,403millionasofDecember31,2023[85]−Thecompany′sretainedearningsasofJune30,2024,were77,349 million, compared to 86,553millionasofDecember31,2023[85]−Thecompany′stotalequityasofJune30,2024,was18,843 million, compared to 28,605millionasofDecember31,2023[85]−CashfromoperatingactivitiesforthesixmonthsendedJune30,2024,was1.905 billion, a significant increase from 226millionin2023[86]−CashusedforinvestingactivitiesforthesixmonthsendedJune30,2024,was3.478 billion, compared to 171millionin2023[86]−CashusedforfinancingactivitiesforthesixmonthsendedJune30,2024,was3.092 billion, compared to 4.394billionin2023[86]−ComprehensiveincomeforthesixmonthsendedJune30,2024,was4.931 billion, compared to 6.212billionin2023[87]−Thecompany′scash,cashequivalents,andrestrictedcashatJune30,2024,were14.947 billion, compared to 14.832billionin2023[86]−Thecompany′stotalequitybalanceatJune30,2024,was18.843 billion, compared to 32.393billionin2023[87]−GEVernova′scashbalanceonthedateofseparationwas4,242 million, with GE Aerospace contributing 515milliontofundfutureoperations[94]−GEAerospacecollectednetcashof477 million related to transition services and sales of engines and parts to GE Vernova for the three months ended June 30, 2024[95] - GE Aerospace collected net cash of 157millionrelatedtotransitionservicesandotheractivitieswithGEHealthCareforthesixmonthsendedJune30,2024[97]−Thecompanyrepurchased13.9millionsharesfor2,289 million during the three months ended June 30, 2024, and 15.0 million shares for 2,434millionduringthesixmonthsendedJune30,2024[147]SegmentPerformance−EquipmentrevenuesforQ22024decreasedto2.2 billion from 2.5billioninQ22023,primarilyduetolowerdeliveriesofnewengines[18]−ServicesrevenuesforQ22024increasedto6.0 billion from 5.4billioninQ22023,drivenbyhigherinternalshopvisitvolumeandprices[18]−SegmentrevenuesforthethreemonthsendedJune30,2024increasedby0.4 billion (7%) to 6.1billion,withsegmentprofitup0.3 billion (21%) to 1.7 billion[29] - Defense & Systems segment revenues for the three months ended June 30, 2024 were 1.5 billion, with segment profit increasing to 344millionandasegmentprofitmarginof14.30.1 billion (71%) for the three months ended June 30, 2024, driven by growth in Propulsion & Additive Technologies[39] - For the six months ended June 30, 2024, segment revenues increased by 0.4billion(90.2 billion (49%), with growth in both Defense & Systems and Propulsion & Additive Technologies[41] - Commercial Engines & Services (CES) has a commercial engine fleet in service of approximately 44,000 units, with 13,000 units under long-term service agreements[27] - Total segment revenues for the six months ended June 30, 2024, were 16.941billion,upfrom15.310 billion in 2023[177] - Commercial Engines & Services segment revenue for Q2 2024 was 6.132billion,a6.95.737 billion in Q2 2023[177] - Defense & Propulsion Technologies segment revenue for Q2 2024 was 2.401billion,slightlyupfrom2.375 billion in Q2 2023[177] - Corporate & Other segment reported a loss of 534millioninQ22024,comparedtoalossof84 million in Q2 2023[177] Remaining Performance Obligations (RPO) - Remaining performance obligation (RPO) as of June 30, 2024, increased by 5.8billion(4159.8 billion, driven by Commercial Engines & Services and Defense & Propulsion Technologies[16] - The remaining performance obligation as of June 30, 2024, was 159.765billion,with19.191 billion related to equipment and 140.574billionrelatedtoservices[177]−Equipment−relatedremainingperformanceobligationisexpectedtobe3729.0 billion as of Q2 2024[74] - Approximately 16 billion of GE Vernova's RPO related to GE Aerospace credit support is expected to mature within five years post-spin-off[74] Corporate and Other Costs - Corporate & Other operating costs increased by 0.5 billion for the three months ended June 30, 2024, primarily due to 0.8 billion of lower gains on retained and sold ownership interests and other equity securities[44] - For the six months ended June 30, 2024, Corporate & Other operating profit decreased by 5.6 billion, mainly due to 6.0 billion of lower gains on retained and sold ownership interests and other equity securities[45] - Adjusted Corporate & Other operating costs decreased by 0.1 billion for both the three and six months ended June 30, 2024, primarily due to a reduction in core functional costs[44][45] - Pre-tax separation costs for Q2 2024 were 75million,downfrom163 million in Q2 2023, as the company completed its spin-off of GE Vernova[154] - The company recognized 216millionofnettaxbenefitforQ22024relatedtoseparationactivities,includingdeferredtaxbenefitsfromstatetaxattributes[154]TaxandAccounting−Theeffectiveincometaxratewas8.67,338 million as of June 30, 2024, compared to 7,502millionattheendof2023[145]−ThecompanyisevaluatingtheimpactofnewFASBaccountingstandardsonsegmentreportingandincometaxdisclosures,effectivefromfiscalyearsbeginningafterDecember15,2024[70][71]ShareRepurchasesandInvestments−Thecompanyrepurchased11.7millionsharesfor1.9 billion during the three months ended June 30, 2024, under a 15.0billionsharerepurchaseauthorization[59]−Thecompanyrepurchased11,700thousandsharesfor1,946 million under the 15billionsharerepurchaseauthorizationduringthethreemonthsendedJune30,2024[81]−Thecompanyrepurchased13.9millionsharesfor2,289 million during the three months ended June 30, 2024, and 15.0 million shares for 2,434millionduringthesixmonthsendedJune30,2024[147]−Thecompany′sinvestmentinGEHealthCarecomprises30.5millionshares(6.72.602 billion received from share dispositions in H1 2024[149] - GE Aerospace held 30.5 million shares (approximately 6.7% ownership interest) in GE HealthCare as of June 30, 2024[104] - The estimated fair value of investment securities decreased to 38,129millionatJune30,2024from38,000 million at December 31, 2023, primarily due to share sales of GE HealthCare equity interest and higher market yields[106] - Total estimated fair value of debt securities in an unrealized loss position were 21,476millionatJune30,2024,with16,283 million having gross unrealized losses of (2,813)millionandbeinginalosspositionfor12monthsormore[107]−Grossunrealizedlossesof(2,946) million at June 30, 2024 included (2,122)millionrelatedtoU.S.corporatesecurities,(138) million related to commercial mortgage-backed securities, and (71)millionrelatedtoAsset−backedsecurities[107]−ThemajorityofequitysecuritiesareclassifiedwithinLevel1anddebtsecuritieswithinLevel2,with7,088 million of investments classified within Level 3 at June 30, 2024[110] - The company holds 1,141millionofequitysecuritieswithoutreadilydeterminablefairvalueatJune30,2024,primarilylimitedpartnershipinvestmentsinprivateequity,infrastructure,andrealestatefunds[111]−InvestmentsinunconsolidatedVIEsincreasedto7,260 million at June 30, 2024 from 6,577millionatDecember31,2023[165]−Totalinvestmentcommitmentswere3,930 million at June 30, 2024, including 3,671millionforunconsolidatedVIEs[166]InsuranceandLong−TermCare−Insurancecashandcashequivalentsroseto1,442 million at June 30, 2024, compared to 784millionatDecember31,2023[123]−Futurepolicybenefitreservesdecreasedto35,376 million at June 30, 2024, down from 37,689millionatDecember31,2023[127]−Presentvalueofexpectednetpremiumsforlong−termcaredecreasedto3,803 million at June 30, 2024, from 4,134millionatJune30,2023[130]−Grosspremiumsforlong−termcarewere242 million for the six months ended June 30, 2024, compared to 246millionforthesameperiodin2023[130]−Benefitpaymentsforlong−termcarewere29,105 million at June 30, 2024, compared to 30,022millionatJune30,2023[131]−Benefitpaymentsforstructuredsettlementannuitieswere8,700 million at June 30, 2024, compared to 9,224millionatJune30,2023[131]−Policyholdersaccountbalancestotaled1,654 million as of June 30, 2024, a decrease from 1,884millionin2023,primarilyduetosurrenders,withdrawals,andbenefitpaymentsof215 million, partially offset by net additions from separate accounts and interest credited of 142million[133]−Thecompanyprovidedatotalof15,035 million in capital contributions to its run-off insurance subsidiaries since 2018, including a final contribution of $1,820 million in Q1 2024[134] - The company signed an agreement in June 2024 to exit a block of its life and health insurance business via an assumption reinsurance transaction, pending regulatory approvals